Transient leukemia of Down syndrome

Crit Rev Clin Lab Sci. 2019 Jun;56(4):247-259. doi: 10.1080/10408363.2019.1613629. Epub 2019 Jun 21.

Abstract

Childhood leukemia is mostly a "developmental accident" during fetal hematopoiesis and may require multiple prenatal and postnatal "hits". The World Health Organization defines transient leukemia of Down syndrome (DS) as increased peripheral blood blasts in neonates with DS and classifies this type of leukemia as a separate entity. Although it was shown that DS predisposes children to myeloid leukemia, neither the nature of the predisposition nor the associated genetic lesions have been defined. Acute myeloid leukemia of DS is a unique disease characterized by a long pre-leukemic, myelodysplastic phase, unusual chromosomal findings and a high cure rate. In the present manuscript, we present a comprehensive review of the literature about clinical and biological findings of transient leukemia of DS (TL-DS) and link them with the genetic discoveries in the field. We address the manuscript to the pediatric generalist and especially to the next generation of pediatric hematologists.

Keywords: Down syndrome; acute leukemia; transient myelosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Down Syndrome / complications*
  • Down Syndrome / genetics
  • Down Syndrome / therapy
  • Genetic Predisposition to Disease
  • Humans
  • Leukemoid Reaction / complications*
  • Leukemoid Reaction / genetics
  • Leukemoid Reaction / therapy

Supplementary concepts

  • Myeloproliferative Syndrome, Transient